Sandwich, United Kingdom

Larence Howard Skillern

This inventor holds 1 USPTO granted patent. Top assignee: Warner Chilcott Company, LLC. Active years: 2014.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Larence Howard Skillern

Introduction

Larence Howard Skillern is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of medicine, particularly in the treatment of overactive bladder conditions. His innovative work has led to the development of a patented medication that addresses a common yet often distressing health issue.

Latest Patents

Skillern holds a patent for the use of darifenacin in the treatment of urgency induced by overactive bladder. This invention provides the use of darifenacin, or a pharmaceutically acceptable derivative thereof, in the manufacture of a medicament aimed at reducing urgency in patients suffering from this condition. His patent is a testament to his commitment to improving patient care and quality of life.

Career Highlights

Skillern is associated with Warner Chilcott Company, LLC, where he has been instrumental in advancing pharmaceutical innovations. His work has not only contributed to the company's portfolio but has also had a positive impact on the healthcare industry.

Collaborations

Throughout his career, Skillern has collaborated with talented individuals such as Dzelal Serdarevic and Paul Quinn. These partnerships have fostered a creative environment that encourages the development of groundbreaking medical solutions.

Conclusion

Larence Howard Skillern's contributions to the field of medicine through his patent on darifenacin highlight his dedication to innovation and improving patient outcomes. His work exemplifies the vital role inventors play in advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…